Clinical trial

Cancer Genome Atlas of China:Lung Cancer

NCT04266483

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

Cancer Genome Atlas of China:Lung Cancer

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-11-08

PhaseN/A

Conditions

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

Sponsors & collaborators

Xuanwu Hospital, Beijinglead sponsor

ChosenMed Technology (Beijing) Co.,Ltdcollaborator

Mapped research locations

BeijingChina11 HangzhouZhejiang, China3 ChangchunJilin, China3 ShenyangLiaoning, China3 HarbinHeilongjiang, China3 GuangzhouGuangdong, China2 ShanghaiChina2 JinanShandong, China1 TianjinChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04266483 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.